C. Llorente

500 total citations
36 papers, 404 citations indexed

About

C. Llorente is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, C. Llorente has authored 36 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 10 papers in Urology. Recurrent topics in C. Llorente's work include Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (13 papers) and Bladder and Urothelial Cancer Treatments (10 papers). C. Llorente is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (13 papers) and Bladder and Urothelial Cancer Treatments (10 papers). C. Llorente collaborates with scholars based in Spain, Argentina and France. C. Llorente's co-authors include Pablo David Bilmes, Virginia Hernández, Juan E. Perez Ipiña, J. Ovejero-Garcı́a, P. Bruzzoni, Francisco Javier Díaz Pernas, Elia Pérez‐Fernández, Mario G. Solari, Alejandro G. González and M.D. Pereda and has published in prestigious journals such as Electrochimica Acta, Journal of Lipid Research and Corrosion Science.

In The Last Decade

C. Llorente

36 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Llorente Spain 11 157 143 119 111 59 36 404
Carlos Llorente Spain 11 353 2.2× 82 0.6× 299 2.5× 213 1.9× 75 1.3× 36 712
Nobuo Ōhashi Japan 8 323 2.1× 24 0.2× 143 1.2× 225 2.0× 136 2.3× 52 539
Bangjian Yang China 10 92 0.6× 73 0.5× 24 0.2× 25 0.2× 9 0.2× 15 255
Alberto Martínez-Martínez Spain 12 170 1.1× 125 0.9× 3 0.0× 94 0.8× 50 0.8× 65 461
Peter J. Brofman United States 10 273 1.7× 17 0.1× 100 0.8× 189 1.7× 86 1.5× 18 445
Margret Kiehn Germany 4 39 0.2× 217 1.5× 34 0.3× 117 1.1× 21 0.4× 6 457
Chenggang Li China 12 314 2.0× 44 0.3× 27 0.2× 153 1.4× 41 0.7× 27 440
ほか Japan 4 241 1.5× 35 0.2× 12 0.1× 111 1.0× 93 1.6× 80 400
J. S. Wolf United States 5 133 0.8× 29 0.2× 7 0.1× 199 1.8× 43 0.7× 6 407
Baoshuai Zhang China 12 164 1.0× 62 0.4× 4 0.0× 98 0.9× 31 0.5× 30 357

Countries citing papers authored by C. Llorente

Since Specialization
Citations

This map shows the geographic impact of C. Llorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Llorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Llorente more than expected).

Fields of papers citing papers by C. Llorente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Llorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Llorente. The network helps show where C. Llorente may publish in the future.

Co-authorship network of co-authors of C. Llorente

This figure shows the co-authorship network connecting the top 25 collaborators of C. Llorente. A scholar is included among the top collaborators of C. Llorente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Llorente. C. Llorente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Sairah, John F. DiPersio, James Essell, et al.. (2025). NKTR-255 Vs Placebo to Enhance Complete Responses and Durability Following CD19-Directed CAR-T Therapy in Patients with Relapsed/ Refractory (R/R) Large B-Cell Lymphoma (LBCL). Transplantation and Cellular Therapy. 31(2). S11–S12. 1 indexed citations
2.
Rubio-García, Elisa, Jany Dandurand, Ana Cenarro, et al.. (2024). ApoB100 remodeling and stiffened cholesteryl ester core raise LDL aggregation in familial hypercholesterolemia patients. Journal of Lipid Research. 66(1). 100703–100703. 2 indexed citations
3.
Castro, Antoni, et al.. (2022). Population based study of morbidity and mortality rates associated to radical prostatectomy cases in Spain. Actas Urológicas Españolas (English Edition). 46(10). 619–628. 1 indexed citations
4.
Hernández, Virginia, et al.. (2017). Influencia de la localización y del número de metástasis en la supervivencia de los pacientes con cáncer de próstata metastásico. Actas Urológicas Españolas. 41(4). 226–233. 6 indexed citations
5.
Hernández, Virginia, et al.. (2017). Influence of the location and number of metastases in the survival of metastatic prostatic cancer patients. Actas Urológicas Españolas (English Edition). 41(4). 226–233. 7 indexed citations
6.
Llorente, C., et al.. (2016). Variabilidad en las complicaciones y la mortalidad quirúrgica tras cistectomía radical en España. Actas Urológicas Españolas. 41(1). 32–38. 11 indexed citations
7.
Capitán, Carlos, et al.. (2015). Estudio de cohortes comparando fotovaporización prostática con láser XPS 180W y HPS 120W. Actas Urológicas Españolas. 40(1). 49–54. 1 indexed citations
8.
Hernández, Virginia, et al.. (2015). Rentabilidad diagnóstica y complicaciones de la linfadenectomía ampliada frente a la limitada asociada a prostatectomía radical. Actas Urológicas Españolas. 40(2). 75–81. 2 indexed citations
9.
Hernández, Virginia, et al.. (2014). Cambios en el grado de Gleason en las biopsias de seguimiento de pacientes con cáncer de próstata en programa de vigilancia activa. Actas Urológicas Españolas. 39(3). 139–143. 3 indexed citations
10.
Pernas, Francisco Javier Díaz, et al.. (2014). Optimización de un programa de alta precoz tras prostatectomía radical laparoscópica. Actas Urológicas Españolas. 38(6). 355–360. 6 indexed citations
11.
Hernández, Virginia, et al.. (2013). Vigilancia activa en cáncer de próstata de bajo riesgo. Aceptación por el paciente y resultados. Actas Urológicas Españolas. 37(9). 533–537. 10 indexed citations
12.
Hernández, Virginia, et al.. (2013). Resultados oncológicos en pacientes potencialmente candidatos a vigilancia activa sometidos a prostatectomía radical. Actas Urológicas Españolas. 37(10). 603–607. 4 indexed citations
13.
Pereda, M.D., et al.. (2012). Impact of Surface Treatment on the Corrosion Resistance of ASTM F138-F139 Stainless Steel for Biomedical Applications. Procedia Materials Science. 1. 446–453. 14 indexed citations
14.
Pereda, M.D., et al.. (2011). Uncertainty studies of topographical measurements on steel surface corrosion by 3D scanning electron microscopy. Micron. 43(2-3). 387–395. 15 indexed citations
15.
Pina‐Camacho, Laura, Jessica Merchán‐Naranjo, M. García-Amador, et al.. (2011). P.7.c.003 Obesogenic capacity of second-generation antipsychotics in naïve-adolescents and their impact on leptin, adiponectin and ghrelin. European Neuropsychopharmacology. 21. S605–S606. 1 indexed citations
16.
Hernández, Virginia, et al.. (2010). External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer. World Journal of Urology. 29(4). 409–414. 49 indexed citations
17.
Hernández, Vicent, et al.. (2010). 1037 EXTERNAL VALIDATION AND APPLICABILITY OF THE EORTC RISK TABLES FOR NON MUSCLE-INVASIVE BLADDER CANCER. European Urology Supplements. 9(2). 324–325. 1 indexed citations
18.
Hernández, Virginia, et al.. (2009). Safety of Active Surveillance Program for Recurrent Nonmuscle-invasive Bladder Carcinoma. Urology. 73(6). 1306–1310. 30 indexed citations
19.
Bilmes, Pablo David, C. Llorente, & Juan E. Perez Ipiña. (2000). Toughness and Microstructure of 13Cr4NiMo High-Strength Steel Welds. Journal of Materials Engineering and Performance. 9(6). 609–615. 55 indexed citations
20.
Luján, M., C. Llorente, Ignacio Romero, et al.. (1997). Application of Self-ExpandingStents in Prostate Cancer withRectal Involvement. European Urology. 31(2). 251–253. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Llorente Breakdown of academic impact, for papers by Nobuo Ōhashi Breakdown of academic impact, for papers by Bangjian Yang Breakdown of academic impact, for papers by Alberto Martínez-Martínez Breakdown of academic impact, for papers by Peter J. Brofman Breakdown of academic impact, for papers by Margret Kiehn Breakdown of academic impact, for papers by Chenggang Li Breakdown of academic impact, for papers by ほか Breakdown of academic impact, for papers by J. S. Wolf Breakdown of academic impact, for papers by Baoshuai Zhang
Rankless by CCL
2026